2008
DOI: 10.2478/v10034-008-0019-8
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Analysis of Friedreich's Ataxia in Macedonian Patients

Abstract: Friedreich's ataxia (FRDA) is rare a progressive neuro degenerative disorder of autosomal recessive inheritance, which is associated with an unstable expansion of a GAA trinucleotide repeat in the first intron of the frataxin gene on chromosome 9q13. We have performed molecular analyses of the frataxin gene of 40 patients with spino cerebellar ataxia from the Republic of Macedonia. Fifteen had early onset of progressive ataxia (before the age of 25), while the remainder were over 25 years old at the time of di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 14 publications
(16 reference statements)
0
2
0
Order By: Relevance
“…Therefore, the presence of expanded GAA repeats in first intron of the FXN gene is used as basis for molecular diagnosis of FRDA in most of the cases. Many techniques have been explored for estimating GAA repeat size [2,[13][14][15][16][17][18][19]. Occurrence of FRDA has been reported to be less frequent in Indian population [30].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, the presence of expanded GAA repeats in first intron of the FXN gene is used as basis for molecular diagnosis of FRDA in most of the cases. Many techniques have been explored for estimating GAA repeat size [2,[13][14][15][16][17][18][19]. Occurrence of FRDA has been reported to be less frequent in Indian population [30].…”
Section: Discussionmentioning
confidence: 99%
“…However, since many neurological disorders share similar symptoms, it is necessary to use molecular diagnostic tests to confirm the diagnosis. Many diagnostic techniques for FRDA are available based on analysis of DNA [2,[13][14][15][16][17][18][19] as well as measurement of frataxin mRNA [20] and protein levels [21][22][23][24]. Also, many mutations have been identified in the FXN gene [2,14,[25][26][27][28][29].…”
Section: Introductionmentioning
confidence: 99%